Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending May 2012. The document serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, specifically regarding changes in share interests.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a specific share transaction notification and does not contain financial statements or performance metrics.
Material Changes
No material changes to the company's financial position or operations are reported in this document. The only change noted is a minor acquisition of shares by a connected person under a specific plan.
Guidance, Outlook, and Risks
The filing contains no management commentary, guidance, outlook, or discussion of risks and contingencies. It strictly details a transaction executed on May 10, 2012, where Mrs. K Thomson (connected to Director Mr. P C Thomson) acquired 2 Ordinary Shares via personal contribution and 2 Ordinary Shares via the Company's matching contribution under the ShareReward Plan. The purchase price was 1407.36 pence per share.
Investor Verification Points
- Verify the total shareholding of Mr. P C Thomson and Mrs. K Thomson following this transaction.
- Confirm the terms of the ShareReward Plan regarding matching contributions.
- Note that this filing does not reflect the company's broader financial performance for the period.